Report cover image

Global Biological Safety Testing Products and Services Market Size Study, By Product (Reagents & Kits, Instruments, Services), By Application (Vaccines & Therapeutics, Gene Therapy, Blood & Blood-based Products, Tissue & Tissue-based Products, Stem Cells)

Publisher Factview Research
Published Oct 03, 2025
Length 285 Pages
SKU # FAVR20464085

Description

The global biological safety testing products and services market was valued at approximately USD 5.06 billion in 2024 and is anticipated to expand at a CAGR of 11.2% over the forecast period 2025-2034. Increasing demand for biologics, vaccines, and gene therapy products has propelled the need for stringent safety evaluations, fostering the adoption of biological safety testing solutions. As regulatory authorities impose rigorous safety standards for pharmaceutical and biopharmaceutical products, the demand for innovative testing methodologies is increasing.

Biological safety testing ensures that pharmaceutical and biologics manufacturing processes remain free from contamination. Rising government funding and private investments in drug development, coupled with the expansion of biotechnology and pharmaceutical industries, have further boosted the adoption of advanced biological safety testing methods. Companies are prioritizing regulatory compliance to mitigate risks associated with microbial contamination, residual host-cell proteins, and endotoxin levels. For instance, in 2024, Charles River Laboratories expanded its safety testing capabilities with enhanced in vitro testing solutions, catering to the evolving needs of biopharmaceutical developers.

Furthermore, the growing focus on personalized medicine and gene therapies has necessitated advanced biological safety testing protocols. The rise in cell-based therapies and monoclonal antibodies (mAbs) has heightened concerns regarding product integrity, sterility, and safety. Regulatory bodies such as the FDA, EMA, and WHO have implemented stringent guidelines requiring robust biological safety testing at various stages of development and manufacturing. Technological advancements, including CRISPR-based testing methods and next-generation sequencing (NGS), have further enhanced testing accuracy and efficiency.

Despite these positive trends, high costs associated with biological safety testing instruments and services remain a challenge for small and mid-sized biopharmaceutical firms. However, ongoing technological advancements, the emergence of AI-driven biosafety solutions, and the increasing integration of automated testing platforms are expected to reduce operational costs over time. Additionally, market players are focusing on expanding their service portfolios through acquisitions and strategic partnerships. In January 2024, Thermo Fisher Scientific acquired a major stake in a biosafety testing service provider to enhance its global presence and strengthen its regulatory compliance capabilities.

Major Market Players Included in this Report Are:
  • Charles River Laboratories
  • Thermo Fisher Scientific Inc.
  • Merck KGaA (MilliporeSigma)
  • Lonza
  • Eurofins Scientific
  • SGS Société Générale de Surveillance SA
  • Samsung Biologics
  • Sartorius AG
  • BIOMÉRIEUX
  • BSL Bioservice
  • FUJIFILM Diosynth Biotechnologies
  • Nelson Labs
  • Wuxi AppTec
  • Cytovance Biologics
  • StemExpress
The Detailed Segments and Sub-segments of the Market are Explained Below:

By Product:
  • Reagents & Kits
  • Instruments
  • Services
By Application:
  • Vaccines & Therapeutics
  • Vaccines
  • Monoclonal Antibodies
  • Recombinant Proteins
  • Blood & Blood-based Products
  • Gene Therapy
  • Tissue & Tissue-based Products
  • Stem Cells
By Test Type:
  • Endotoxin Tests
  • Sterility Tests
  • Cell Line Authentication & Characterization Tests
  • Bioburden Tests
  • Adventitious Agent Detection Tests
  • Residual Host Contamination Detection Tests
  • Others
By Region:

North America
  • U.S.
  • Canada
Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
Latin America
  • Brazil
  • Mexico
  • Argentina
Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
Years considered for the study are as follows:
  • Historical Year – 2022
  • Base Year – 2024
  • Forecast Period – 2024 to 2034
Key Takeaways:
  • Market Estimates & Forecast for 10 years (2022-2034)
  • Annualized revenues & regional-level analysis for each market segment
  • Geographical landscape analysis with country-level market insights
  • Competitive landscape with information on major market players
  • Key business strategies & investment recommendations
  • Competitive structure & demand-supply analysis
  • Comprehensive regulatory framework overview impacting market growth

Table of Contents

285 Pages
Chapter 1. Global Biological Safety Testing Products and Services Market Executive Summary
1.1. Global Market Size & Forecast (2024-2034)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.2. By Application
1.3.3. By Test Type
1.4. Key Market Trends
1.5. Recession Impact Analysis
1.6 Industry Metrics
1.7 Investment Analysis
1.8 Investment Rationale
1.9. Analyst Recommendation & Conclusion
Chapter 2. Global Biological Safety Testing Products and Services Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Biological Safety Testing Products and Services Market Dynamics
3.1. Market Drivers
3.1.1. Rising demand for biologics and biosimilars
3.1.2. Stringent regulatory policies for pharmaceutical safety
3.1.3. Growing investment in biopharmaceutical R&D
3.2. Market Challenges
3.2.1. High costs associated with biological safety testing
3.2.2. Complexities in biologics testing and regulatory approvals
3.3. Market Opportunities
3.3.1. Advancements in genetic and cell-based assays
3.3.2. Emerging markets in Asia-Pacific driving demand
Chapter 4. Global Biological Safety Testing Products and Services Market Industry Analysis
4.1. Porter’s Five Forces Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s Five Forces Model
4.1.7. Porter’s Five Forces Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political Factors
4.2.2. Economic Factors
4.2.3. Social Factors
4.2.4. Technological Factors
4.2.5. Environmental Factors
4.2.6. Legal Factors
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends in Biological Safety Testing
4.6. Industry Expert Perspectives
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Biological Safety Testing Products and Services Market Size & Forecasts by Product (2024-2034)
5.1. Segment Dashboard
5.2. Global Market: Product Revenue Trend Analysis (2022 & 2032)
5.2.1. Reagents & Kits
5.2.2. Instruments
5.2.3. Services
Chapter 6. Global Biological Safety Testing Products and Services Market Size & Forecasts by Application (2024-2034)
6.1. Segment Dashboard
6.2. Global Market: Application Revenue Trend Analysis (2022 & 2032)
6.2.1. Vaccines & Therapeutics
6.2.1.1. Vaccines
6.2.1.2. Monoclonal Antibodies
6.2.1.3. Recombinant Protein
6.2.2. Blood & Blood-based Products
6.2.3. Gene Therapy
6.2.4. Tissue & Tissue-based Products
6.2.5. Stem Cell Therapy
Chapter 7. Global Biological Safety Testing Products and Services Market Size & Forecasts by Test Type (2024-2034)
7.1. Segment Dashboard
7.2. Global Market: Test Type Revenue Trend Analysis (2022 & 2032)
7.2.1. Endotoxin Tests
7.2.2. Sterility Tests
7.2.3. Cell Line Authentication & Characterization Tests
7.2.4. Bioburden Tests
7.2.5. Adventitious Agent Detection Tests
7.2.6. Residual Host Contamination Detection Tests
7.2.7. Others
Chapter 8. Global Biological Safety Testing Products and Services Market Size & Forecasts by Region (2024-2034)
8.1. North America Market
8.1.1. U.S. Market
8.1.2. Canada Market
8.2. Europe Market
8.2.1. UK Market
8.2.2. Germany Market
8.2.3. France Market
8.2.4. Italy Market
8.2.5. Spain Market
8.2.6. Denmark Market
8.2.7. Sweden Market
8.2.8. Norway Market
8.3. Asia-Pacific Market
8.3.1. Japan Market
8.3.2. China Market
8.3.3. India Market
8.3.4. South Korea Market
8.3.5. Australia Market
8.3.6. Thailand Market
8.4. Latin America Market
8.4.1. Brazil Market
8.4.2. Mexico Market
8.4.3. Argentina Market
8.5. Middle East & Africa Market
8.5.1. South Africa Market
8.5.2. Saudi Arabia Market
8.5.3. UAE Market
8.5.4. Kuwait Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Charles River Laboratories
9.1.2. Merck KGaA
9.1.3. Thermo Fisher Scientific Inc.
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Charles River Laboratories
9.3.2. BSL Bioservice
9.3.3. Merck KGaA (MilliporeSigma)
9.3.4. Samsung Biologics
9.3.5. Sartorius AG
9.3.6. Eurofins Scientific
9.3.7. SGS Société Générale de Surveillance SA
9.3.8. Thermo Fisher Scientific Inc.
9.3.9. BIOMÉRIEUX
9.3.10. Lonza
Chapter 10. Research Process
10.1. Research Process Overview
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us